The Patented Medicine Prices Review Board looked at the possibility of increasing the number of countries against which we can compare the prices of Canadian drugs in order to be able to offer Canadians—all while paying a fair price—drugs at a lower price, just by expanding the range of comparable countries from seven to 13.
Does the minister intend to take this approach and, therefore, allow Canadians to save more than $2 billion on drug prices?